Articles by Disease (Heart Rupture)

Pharmacogenomic Considerations of the Insertion / Deletion Gene Polymorphism of the Angiotensin I-Converting Enzyme and Coronary Artery Disease

Journal: Current Vascular Pharmacology
Volume: 2
Page: 271-279
Author(s): Danije Petrovic and Borut Peterlin

The Adipose Tissue as a Source of Vasoactive Factors

Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 2
Page: 197-208
Author(s): G. Frühbeck

Direct Antithrombins: New Perspectives in Cardiovascular Medicine

Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 2
Page: 267-275
Author(s): M. Lettino and V. Toschi

Single Molecule Techniques for Biomedicine and Pharmacology

Journal: Current Pharmaceutical Biotechnology
Volume: 5
Page: 243-257
Author(s): K. O. Greulic

Molecular Basis of Antiretroviral Drugs-Associated Long-Term Toxicity: How Bad can Good Drugs Be?

Journal: Current Medicinal Chemistry - Anti-Infective Agents
Volume: 3
Page: 109-133
Author(s): Pere Domingo, Francesc Vidal and Joan Carles Domingo

Carotid Intima Media Thickness and Beyond

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 4
Page: 129-145
Author(s): Jacques D. Barth

Image-based Computational Fluid Dynamics: A New Paradigm for Monitoring Hemodynamics and Atherosclerosis

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 4
Page: 183-197
Author(s): David A. Steinman

Intravenous Glycoprotein IIb / IIIa Antagonists: Their Benefits, Problems and Future Developments

Journal: Current Pharmaceutical Design
Volume: 10
Page: 1577-1585
Author(s): Ronan Curtin

Profiling the Shear Stress of Atherosclerosis; A Genomic View

Journal: Current Genomics
Volume: 5
Page: 287-297
Author(s): C. Stenson-Cox, V. Barron, B. P. Murphy, P. E. McHugh and T. Smith

Prostaglandin J2 Family and the Cardiovascular System

Journal: Current Vascular Pharmacology
Volume: 2
Page: 103-114
Author(s): Toshiyuki Sasaguri and Yoshikazu Miwa